Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema
- 1 September 1999
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 43 (2-3) , 293-302
- https://doi.org/10.1016/s0162-3109(99)00133-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Angiotensin‐converting enzyme inhibitor‐induced angioedema: late onset, irregular course, and potential role of triggersAllergy, 1997
- Angiotensin–converting enzyme (ACE) inhibitors and angio–oedemaBritish Journal of Dermatology, 1997
- Pathophysiology and clinical presentations of cough☆☆☆★Journal of Allergy and Clinical Immunology, 1996
- Development of digoxigenin-labeled peptide: Application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissuesPeptides, 1994
- Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors.BMJ, 1992
- Angioedema: Manifestations and managementJournal of the American Academy of Dermatology, 1991
- Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: The effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamineJournal of Allergy and Clinical Immunology, 1990
- Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme.BMJ, 1987
- Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.BMJ, 1987
- Prekallikrein Activation and High-Molecular-Weight Kininogen Consumption in Hereditary AngioedemaNew England Journal of Medicine, 1983